We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrx CEO Awarded $700K Bonus Despite GMP Violations
Andrx CEO Awarded $700K Bonus Despite GMP Violations
April 26, 2006
Andrx’s CEO will get a $700,000 bonus for 2005 despite manufacturing problems that have stalled all the company’s pending drug applications, according to documents filed with the Securities and Exchange Commission (SEC).